Fredun Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Fredun Pharmaceuticals Ltd. on BSE

Load latest

Fredun Pharmaceuticals Ltd.

15 Apr 2025

1213.00

-0.31%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate Pursuant to Regulation 74(5) of the SEBI (DP) Reg, 2018

pdf

Fredun Pharmaceuticals Ltd.

09 Apr 2025

1213.00

-0.31%

Corp. Note

Fredun Pharmaceuticals Ltd - 539730 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyFredun Pharmaceuticals Ltd 2CIN NO.L24239MH1987PLC043662 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: JINKAL SHAH Designation: COMPANY SECRETARY AND COMPLIANCE OFFICIER EmailId: CS@FREDUNGROUP.COM Name of the Chief Financial Officer: FREDUN MEDHORA Designation: CFO AND MD EmailId: FREDUN@FREDUNGROUP.COM Date: 09/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Fredun Pharmaceuticals Ltd.

09 Apr 2025

1213.00

-0.31%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

The company has secured a tender from Tamil Nadu Medical Services Corporation (TNMSC) for the supply of generic medicines,valued between Rs.150 million and Rs. 180 million

pdf

Fredun Pharmaceuticals Ltd.

03 Apr 2025

1213.00

-0.31%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

BSE India

Announcement regarding upgradation of ratings assigned to its bank facilities by Infomerics Valuation and Rating Ltd.The upgrade reflects the company''s strong financial performance and operational resilence.

pdf

Fredun Pharmaceuticals Ltd.

27 Mar 2025

1213.00

-0.31%

SAST

Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window

BSE India

Intimation of Closure of trading window

pdf

Fredun Pharmaceuticals Ltd.

18 Mar 2025

1213.00

-0.31%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Fredun Pharma''s Freossi Division Marks Its Entry into Sri Lanka with a Suite of Premium Quality Petcare Products.

pdf

Fredun Pharmaceuticals Ltd.

11 Mar 2025

1213.00

-0.31%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

THE COMPANY ANNOUNCES ITS FORAY INTO THE LARGE ANIMAL VETERINARY SEGMENT BY PROVIDING INNOVATIVE SOLUTIONS FOR LARGE ANIMAL HEALTH TO ADDRESS THEIR KEY HEALTH CHALLENGES.

pdf

Fredun Pharmaceuticals Ltd.

24 Feb 2025

1213.00

-0.31%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Intimation With Respect To The Appointment Of Internal Auditor - …

BSE India

We wish to inform you that based on the recommendation of the Audit Committee, the Board of Directors of the Company has at its meeting held today i.e. on February 24, 2025, has approved the appointment of Nikhil Maniar & Associates., Chartered Accountants (Firm Reg. No. 128056W) as the Internal Auditor of the Company for the Financial year 2024-2025.

pdf